Unicycive Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for UNCY

Based on 3 analysts offering 12 month price targets for Unicycive Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell UNCY stock?

Based on 3 analysts offering ratings for Unicycive Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
1 analysts 33.33%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UNCY stock forecasts and price targets.

UNCY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
EF Hutton
Bottom 7%
Strong BuyInitiates Coverage On$5.00+194.12%2023-03-09
HC Wainwright & Co.
Top 12%
Maxim Group
Bottom 4%
Strong BuyMaintains$6.00+252.94%2023-03-09

1 of 1

UNCY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UNCY$1.70$6.33+272.53%Strong Buy
IMMX$1.86$14.00+652.69%Strong Buy

Unicycive Therapeutics Stock Forecast FAQ

Is Unicycive Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: UNCY) stock is to Strong Buy UNCY stock.

Out of 3 analysts, 2 (66.67%) are recommending UNCY as a Strong Buy, 1 (33.33%) are recommending UNCY as a Buy, 0 (0%) are recommending UNCY as a Hold, 0 (0%) are recommending UNCY as a Sell, and 0 (0%) are recommending UNCY as a Strong Sell.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.

What is UNCY's Price Target?

According to 3 Wall Street analysts that have issued a 1 year UNCY price target, the average UNCY price target is $6.33, with the highest UNCY stock price forecast at $8.00 and the lowest UNCY stock price forecast at $5.00.

On average, Wall Street analysts predict that Unicycive Therapeutics's share price could reach $6.33 by Mar 9, 2024. The average Unicycive Therapeutics stock price prediction forecasts a potential upside of 272.53% from the current UNCY share price of $1.70.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.